西妥昔单抗
医学
结直肠癌
内科学
肿瘤科
克拉斯
加药
毒性
药代动力学
养生
置信区间
胃肠病学
癌症
作者
Di Jiang,Shruti Parshad,Luna Jia Zhan,Hao‐Wen Sim,Lillian L. Siu,Geoffrey Liu,Jeremy Shapiro,Timothy Price,Derek J. Jonker,Christos S. Karapetis,Andrew Strickland,Wei Zhang,Mark Jeffery,Dongsheng Tu,Siobhan Ng,Sabe Sabesan,Jenny Shannon,Amanda Townsend,Chris O’Callaghan,Eric X. Chen
标识
DOI:10.1016/j.clcc.2023.08.006
摘要
Cetuximab is a standard of care therapy for patients with RAS wild-type (WT) advanced colorectal cancer. Limited data suggest a wide variation in cetuximab plasma concentrations after standard dosing regimens. We correlated cetuximab plasma concentrations with survival and toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI